| Robert F Calciano, MD | |
|
7210 - 13 Ave 3rd Floor, Brooklyn, NY 11228 | |
| (718) 837-5100 | |
| (718) 837-7762 |
| Full Name | Robert F Calciano |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 46 Years |
| Location | 7210 - 13 Ave 3rd Floor, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861432353 | NPI | - | NPPES |
| 01490853 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 141513 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians' Health Study II.
Recently published in the New England Journal of Medicine, the largest prospective study of chronic hepatitis C virus (HCV) treatments Pegetron and Pegasys RBV (R) found both treatments equal in achieving sustained viral response. The study also found that Pegetron had a significantly lower relapse rate and is a safe and effective treatment option which has shown long term viral eradication.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.
Consumers overwhelmed by options when considering over-the-counter (OTC) medications can now find out which products are most recommended by pharmacists through Pharmacy & Healthcare Communications' OTC Recommendations Survey.
A deep look into a nationwide mass vaccination setting in Israel revealed that the BNT162b2 (Pfizer–BioNTech) vaccine is not linked with an elevated risk of a majority of the adverse events under study, with the exception of myocarditis. However, even that potentially severe adverse event is much more pervasive following the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), found a new study published in the New England Journal of Medicine (NEJM).
› Verified 8 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750647152 PECOS PAC ID: 2264691070 Enrollment ID: O20130920000028 |
News Archive
Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians' Health Study II.
Recently published in the New England Journal of Medicine, the largest prospective study of chronic hepatitis C virus (HCV) treatments Pegetron and Pegasys RBV (R) found both treatments equal in achieving sustained viral response. The study also found that Pegetron had a significantly lower relapse rate and is a safe and effective treatment option which has shown long term viral eradication.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.
Consumers overwhelmed by options when considering over-the-counter (OTC) medications can now find out which products are most recommended by pharmacists through Pharmacy & Healthcare Communications' OTC Recommendations Survey.
A deep look into a nationwide mass vaccination setting in Israel revealed that the BNT162b2 (Pfizer–BioNTech) vaccine is not linked with an elevated risk of a majority of the adverse events under study, with the exception of myocarditis. However, even that potentially severe adverse event is much more pervasive following the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), found a new study published in the New England Journal of Medicine (NEJM).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert F Calciano, MD 7210 - 13 Ave 3rd Floor, Brooklyn, NY 11228 Ph: (718) 837-5100 | Robert F Calciano, MD 7210 - 13 Ave 3rd Floor, Brooklyn, NY 11228 Ph: (718) 837-5100 |
News Archive
Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians' Health Study II.
Recently published in the New England Journal of Medicine, the largest prospective study of chronic hepatitis C virus (HCV) treatments Pegetron and Pegasys RBV (R) found both treatments equal in achieving sustained viral response. The study also found that Pegetron had a significantly lower relapse rate and is a safe and effective treatment option which has shown long term viral eradication.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.
Consumers overwhelmed by options when considering over-the-counter (OTC) medications can now find out which products are most recommended by pharmacists through Pharmacy & Healthcare Communications' OTC Recommendations Survey.
A deep look into a nationwide mass vaccination setting in Israel revealed that the BNT162b2 (Pfizer–BioNTech) vaccine is not linked with an elevated risk of a majority of the adverse events under study, with the exception of myocarditis. However, even that potentially severe adverse event is much more pervasive following the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), found a new study published in the New England Journal of Medicine (NEJM).
› Verified 8 days ago
Lital Fleyshmakher, PA-C Urology Medicare: Not Enrolled in Medicare Practice Location: 770 Ocean Pkwy, Brooklyn, NY 11230 Phone: 718-941-2002 | |
Dr. Lawrence Michael Mcguire, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4802 10th Ave, Brooklyn, NY 11219 Phone: 718-283-7724 Fax: 718-635-7093 | |
Dr. Stephen Robert Baumgarten, MD Urology Medicare: Medicare Enrolled Practice Location: 2301 Ocean Ave, Suite 1a, Brooklyn, NY 11229 Phone: 718-382-8777 Fax: 718-228-8362 | |
Dr. Alexander Marinbakh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2844 Ocean Pkwy, Brooklyn, NY 11235 Phone: 718-646-0909 Fax: 718-646-8688 | |
Jean Garry Lajeune, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 745 64th Street, 4th Floor, Brooklyn, NY 11220 Phone: 718-283-8696 Fax: 718-635-7424 | |
Dr. Simon Saada, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 705 86 Street, Brooklyn, NY 11228 Phone: 718-238-1075 Fax: 718-238-1174 | |
Ben Z Jacobs, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1648 East 14th Street, Suite #2, Brooklyn, NY 11229 Phone: 718-336-6886 Fax: 718-336-3945 |